{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:25:35Z","timestamp":1789129535549,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ctro.2026.101263","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:35:27Z","timestamp":1786466127000},"page":"101263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["VMAT-based lattice radiotherapy for advanced bulky hepatocellular carcinoma within multimodality treatment: a consecutive feasibility series"],"prefix":"10.1016","volume":"61","author":[{"given":"Yu-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Wei","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Wei","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Peng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Lang","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kung-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101263_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2026.101263_bb0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.12111550","article-title":"Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib","volume":"263","author":"Pinter","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.ctro.2026.101263_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ctro.2026.101263_bb0020","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: from infancy to ongoing maturity","volume":"4","author":"Lewis","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ctro.2026.101263_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ctro.2026.101263_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713274","article-title":"Hepatocellular carcinoma: past and present challenges and progress in molecular classification and precision oncology","volume":"24","author":"Coffin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctro.2026.101263_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acr.2022.01.007","article-title":"Implications of genetic heterogeneity in hepatocellular cancer","volume":"156","author":"Suresh","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ctro.2026.101263_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.trecan.2020.01.010","article-title":"Understanding the cause and consequence of tumor heterogeneity","volume":"6","author":"Khatib","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ctro.2026.101263_bb0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41388-023-02935-9","article-title":"TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma","volume":"43","author":"Geng","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ctro.2026.101263_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040872","article-title":"Vinorelbine augments radiotherapy in hepatocellular carcinoma","volume":"12","author":"Yeoh","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101263_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00066-018-1385-0","article-title":"Repeated SBRT for in- and out-of-field recurrences in the liver","volume":"195","author":"Gkika","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2026.101263_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2018.04.012","article-title":"Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis","volume":"8","author":"McDuff","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3349\/ymj.2016.57.1.41","article-title":"Re-irradiation of hepatocellular carcinoma: clinical applicability of deformable image registration","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ctro.2026.101263_bb0070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12328-022-01642-4","article-title":"Long-term survivor of hepatocellular carcinoma treated with repeated carbon ion radiotherapy and transarterial chemoembolization: a case report","volume":"15","author":"Ohtaka","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.ctro.2026.101263_bb0075","doi-asserted-by":"crossref","first-page":"16224","DOI":"10.1038\/s41598-018-34676-1","article-title":"Evaluation of hepatic toxicity after repeated stereotactic body radiation therapy for recurrent hepatocellular carcinoma using deformable image registration","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctro.2026.101263_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102916","article-title":"Tumor microenvironment as a regulator of radiation therapy: new insights into stromal-mediated radioresistance","volume":"12","author":"Krisnawan","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101263_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc.2015.4","article-title":"DNA repair, genome stability and cancer: a historical perspective","volume":"16","author":"Jeggo","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2026.101263_bb0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2026.101263_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/SLA.0b013e31820d944f","article-title":"Hepatocellular carcinoma: current management and perspectives for the future","volume":"253","author":"Rahbari","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101263_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","article-title":"Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a Multicenter study from China","volume":"154","author":"Xu","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ctro.2026.101263_bb0105","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2022.8.FOCUS2255","article-title":"The role of radiation therapy in the treatment of spine metastases from hepatocellular carcinoma: a systematic review and meta-analysis","volume":"53","author":"Ferini","year":"2022","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ctro.2026.101263_bb0110","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1007\/s00330-020-06990-8","article-title":"Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (<\/= 5 cm) after initial curative resection","volume":"30","author":"Feng","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctro.2026.101263_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235532","article-title":"Real-world systemic treatment patterns after atezolizumab and bevacizumab in patients with hepatocellular carcinoma in the United States","volume":"15","author":"Singal","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101263_bb0120","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i7.107815","article-title":"Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence","volume":"17","author":"Liu","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0125","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1245\/s10434-025-17673-3","article-title":"Patterns of site and timing of recurrence after curative resection in single and multiple large hepatocellular carcinoma: a Multicenter international comprehensive analysis","volume":"32","author":"Giannone","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ctro.2026.101263_bb0135","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/cncr.34965","article-title":"Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: results of a randomized clinical trial","volume":"129","author":"Bush","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101263_bb0140","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.3390\/curroncol29110692","article-title":"Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)","volume":"29","author":"Comito","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1200\/JCO-24-01532","article-title":"Radiofrequency ablation versus stereotactic body radiotherapy for recurrent small hepatocellular carcinoma: a randomized, open-label, controlled trial","volume":"43","author":"Xi","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2023.03.064","article-title":"Transarterial chemoembolization with drug-eluting beads versus stereotactic body radiation therapy for hepatocellular carcinoma: outcomes from a multicenter, randomized, phase 2 trial (the TRENDY trial)","volume":"117","author":"Mendez Romero","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101263_bb0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of Transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","article-title":"Stereotactic body radiotherapy vs sorafenib alone in hepatocellular carcinoma: the NRG oncology\/RTOG 1112 phase 3 randomized clinical trial","volume":"11","author":"Dawson","year":"2025","journal-title":"JAMA Oncol"},{"issue":"19","key":"10.1016\/j.ctro.2026.101263_bb0165","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1200\/JCO-25-02399","article-title":"Overall survival among patients with hepatocellular carcinoma treated with external beam radiation therapy: individual patient data outcomes from a multinational cohort","volume":"44","author":"Moon","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2020.10.007","article-title":"VMAT grid therapy: a widely applicable planning approach","volume":"11","author":"Grams","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102616","article-title":"Clinical aspects of spatially fractionated radiation therapy treatments","volume":"111","author":"Grams","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.ctro.2026.101263_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.06.2306","article-title":"Intratumoral dose escalation using lattice radiotherapy for hepatocellular carcinoma with Unfavorable size and location","volume":"117","author":"Frankart","year":"2023","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.ctro.2026.101263_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pro6.1248","article-title":"Feasibility planning study of lattice radiotherapy for palliation in bulky tumors","volume":"8","author":"Np","year":"2024","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0190","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2023.12.013","article-title":"Overview and recommendations for prospective multi-institutional spatially fractionated radiation therapy clinical trials","volume":"119","author":"Li","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101263_bb0195","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad4192","article-title":"Spatially fractionated radiation therapy: a critical review on current status of clinical and preclinical studies and knowledge gaps","volume":"69","author":"Prezado","year":"2024","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2026.101263_bb0200","article-title":"Novel pencil-beam scanning proton lattice radiation therapy for the treatment of bulky liver cancer: dosimetric comparison with VMAT-lattice radiotherapy","volume":"15","author":"Li","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","article-title":"External beam radiation therapy for primary liver cancers: An ASTRO clinical practice guideline","volume":"12","author":"Apisarnthanarax","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/jmp.jmp_97_24","article-title":"Impact of number and placement of high-dose vertices on equivalent uniform dose and peak-to-valley ratio for lattice radiotherapy","volume":"49","author":"Bhagyalakshmi","year":"2024","journal-title":"J Med Phys"},{"key":"10.1016\/j.ctro.2026.101263_bb0215","article-title":"Pencil beam scanning proton lattice radiotherapy: single-field versus multi-field optimization","volume":"15","author":"Wei","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1667\/RADE-20-00047.1","article-title":"Photon GRID radiation therapy: a physics and dosimetry white paper from the radiosurgery society (RSS) GRID\/LATTICE, microbeam and FLASH radiotherapy working group","volume":"194","author":"Zhang","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.ctro.2026.101263_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/acm2.13040","article-title":"A simple dosimetric approach to spatially fractionated GRID radiation therapy using the multileaf collimator for treatment of breast cancers in the prone position","volume":"21","author":"Murphy","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ctro.2026.101263_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2023.08.061","article-title":"Dosimetric validation for prospective clinical trial of GRID collimator-based spatially fractionated radiation therapy: dose metrics consistency and heterogeneous pattern reproducibility","volume":"118","author":"Zhang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101263_bb0235","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.21873\/anticanres.15968","article-title":"First-ever clinical experience with magnetic resonance-based lattice radiotherapy for treating bulky Gynecological Tumors","volume":"42","author":"Ferini","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctro.2026.101263_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2021.11.023","article-title":"LITE SABR M1: a phase I trial of lattice stereotactic body radiotherapy for large tumors","volume":"167","author":"Duriseti","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0245","article-title":"Lattice radiation therapy in clinical practice: a systematic review","volume":"39","author":"Iori","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0250","article-title":"First treatments for lattice stereotactic body radiation therapy using magnetic resonance image guided radiation therapy","volume":"39","author":"Price","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0255","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.21873\/invivo.13719","article-title":"The promising effects of lattice radiotherapy for large, fungating, or ulcerating breast cancers: a prospective single-center study","volume":"38","author":"Ferini","year":"2024","journal-title":"In Vivo"},{"key":"10.1016\/j.ctro.2026.101263_bb0260","article-title":"Spatially fractionated radiotherapy (lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer","volume":"48","author":"Xu","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0265","article-title":"Lattice radiotherapy for extensive liver metastases in synchronous EGFR-mutant lung adenocarcinoma and small cell lung cancer","volume":"54","author":"El Chammah","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172752","article-title":"Diagnosis-related outcome following palliative spatially fractionated radiation therapy (lattice) of large tumors","volume":"17","author":"Studer","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101263_bb0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/oncologie-2025-0435","article-title":"Lattice radiotherapy-induced dramatic regression of bulky metastases challenges radioresistance compared with homogeneous hypofractionation in anorectal mucosal melanoma: a case report","volume":"28","author":"Ferini","year":"2026","journal-title":"Oncologie"},{"key":"10.1016\/j.ctro.2026.101263_bb0280","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41571-026-01161-y","article-title":"The future is not always uniform: rethinking radiotherapy through spatial fractionation","volume":"23","author":"Iori","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update","volume":"84","author":"Reig","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.ctro.2026.101263_bb0290","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2026.44.16_suppl.e16270","article-title":"Lattice SFRT combined with systemic therapy for bulky unresectable hepatocellular carcinoma: a retrospective study on safety and efficacy","volume":"44","author":"Yang","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0295","article-title":"Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio","volume":"44","author":"Lu","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0300","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.semradonc.2024.04.002","article-title":"Spatially fractionated radiotherapy in the era of immunotherapy","volume":"34","author":"McMillan","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0305","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/1078-0432.CCR-23-3632","article-title":"Translational Frontiers and clinical opportunities of immunologically fitted radiotherapy","volume":"30","author":"Morel","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2026.101263_bb0310","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/bjr\/tqae100","article-title":"Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy","volume":"97","author":"Passelli","year":"2024","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2026.101263_bb0315","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s11912-023-01473-7","article-title":"Immune priming with spatially fractionated radiation therapy","volume":"25","author":"Lukas","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ctro.2026.101263_bb0320","article-title":"The use of spatially fractionated radiation therapy combined with immune checkpoint inhibitors and vascular endothelial growth factor inhibitor in the treatment of Giant metastatic hepatocellular carcinoma: a case report","volume":"11","author":"Jin","year":"2026","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0325","first-page":"30","article-title":"Spatially fractionated radiation therapy: history, present and the future","volume":"20","author":"Yan","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101263_bb0330","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1667\/RADE-20-00065.1","article-title":"Evidence for early stage anti-tumor immunity elicited by spatially fractionated radiotherapy-immunotherapy combinations","volume":"194","author":"Johnsrud","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.ctro.2026.101263_bb0335","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ijrobp.2020.03.028","article-title":"Understanding high-dose, ultra-high dose rate, and spatially fractionated radiation therapy","volume":"107","author":"Griffin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:22:37Z","timestamp":1789125757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":67,"alternative-id":["S2405630826001588"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101263","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VMAT-based lattice radiotherapy for advanced bulky hepatocellular carcinoma within multimodality treatment: a consecutive feasibility series","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101263"}}